Hypotensive effect of butein via the inhibition of angiotensin converting enzyme.

Butein (3,4,2',4'-tetrahydroxychalcone), a plant polyphenol, has been known to elucidate endothelium-dependent vasodilation. In the present study, the hypotensive effect of butein and its possible mechanism, especially an angiotensin converting enzyme (ACE) inhibitory effect, were investigated. Intravenous injection of butein lowered the arterial blood pressure of anesthetized rats in a dose-dependent manner. The plasma ACE activities were significantly inhibited by the addition of butein in a dose-dependent manner, the IC(50) value of which was 198 microg/ml (730 microM). Moreover, angiotensin I-induced contraction was markedly attenuated by prior exposure of endothelium-intact aortic rings to butein, but angiotensin II-induced contraction was not altered. These results suggest that butein has a hypotensive effect, at least in part, via the inhibition of angiotensin converting enzyme.

[1]  H. Oh,et al.  Angiotensin converting enzyme inhibitors from Cuscuta japonica Choisy. , 2002, Journal of ethnopharmacology.

[2]  Jeong-Chae Lee,et al.  Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties. , 2002, Biochimica et biophysica acta.

[3]  P. Mack,et al.  Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives. , 2001, Biochimica et biophysica acta.

[4]  P. Sleight.  The role of angiotensinconverting enzyme inhibitors in the treatment of hypertension , 2001, Current cardiology reports.

[5]  M. Nicolau,et al.  Effect of quercetin on tachykinin‐induced plasma extravasation in rat urinary bladder , 2001, Phytotherapy research : PTR.

[6]  M. Mcclellan,et al.  Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. , 2001, The American journal of medicine.

[7]  P. But,et al.  Inhibitory activity of flavonoids and tannins against HIV-1 protease. , 2000, Biological & pharmaceutical bulletin.

[8]  P. Carson.  Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure. , 2000, American heart journal.

[9]  M. Kobori,et al.  Flavonoids Inhibit Cell Growth and Induce Apoptosis in B16 Melanoma 4A5 Cells , 2000, Bioscience, biotechnology, and biochemistry.

[10]  J. van Staden,et al.  Screening of Zulu medicinal plants for angiotensin converting enzyme (ACE) inhibitors. , 1999, Journal of ethnopharmacology.

[11]  F. Cosio,et al.  Combination ACE Inhibitor and Angiotensin II Receptor Antagonist Therapy in Diabetic Nephropathy , 1999, American Journal of Nephrology.

[12]  K. Zhang,et al.  Butein, a specific protein tyrosine kinase inhibitor. , 1998, Biochemical and biophysical research communications.

[13]  U. Nyman,et al.  Ethnomedical information and in vitro screening for angiotensin-converting enzyme inhibition of plants utilized as traditional medicines in Gujarat, Rajasthan and Kerala (India). , 1998, Journal of ethnopharmacology.

[14]  S. Chan,et al.  Three new flavonoids and antiallergic, anti-inflammatory constituents from the heartwood of Dalbergia odorifera. , 1998, Planta medica.

[15]  K. Zhang,et al.  Inhibition of glutathione reductase by plant polyphenols. , 1997, Biochemical pharmacology.

[16]  Y. Suzuki,et al.  Butein ameliorates experimental anti-glomerular basement membrane (GBM) antibody-associated glomerulonephritis in rats (1). , 1996, Japanese journal of pharmacology.

[17]  S. Kuo,et al.  Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor. , 1995, European journal of pharmacology.

[18]  M. Kikuchi,et al.  Purification and identification of an angiotensin I-converting enzyme inhibitor from soy sauce. , 1993, Bioscience, biotechnology, and biochemistry.

[19]  D. Ganten,et al.  Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems. , 1992, The American journal of cardiology.

[20]  H. Wagner,et al.  ACE-Inhibitory Procyanidins from Lespedeza capitata , 1992, Planta medica.

[21]  J. Lin,et al.  Inhibition of angiotensin-I-converting enzyme by tetrahydroxyxanthones isolated from Tripterospermum lanceolatum. , 1992, Journal of natural products.

[22]  Y. Nishi,et al.  Chemical and pharmaceutical studies on medicinal plants in Paraguay. Geraniin, an angiotensin-converting enzyme inhibitor from "paraparai mi," Phyllanthus niruri. , 1988, Journal of natural products.

[23]  T. Hatano,et al.  Inhibitory effects of various flavonoids isolated from leaves of persimmon on angiotensin-converting enzyme activity. , 1987, Journal of natural products.

[24]  N. Ikekawa,et al.  Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. , 1986, Chemical & pharmaceutical bulletin.

[25]  S. Snyder,et al.  Characterization of angiotensin converting enzyme by [3H]captopril binding. , 1986, Molecular pharmacology.

[26]  E. Krieger,et al.  An improved fluorometric assay of rat serum and plasma converting enzyme. , 1985, Hypertension.